MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
Mauro Porcini—and asked him use his approach to design to help the Korean company keep ahead of its competitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback